Late-onset genetic cholestasis encompasses a group of rare, inherited liver disorders, including conditions such as progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome. These conditions are often under-recognized, leading to delayed or missed diagnoses. Existing resources primarily focus on pediatric cases, leaving gaps in awareness about the less severe and varied symptoms that can appear into adulthood.
This expert-led program will allow you to effectively recognize and diagnose late-onset genetic cholestasis and its associated conditions, and make informed decisions on individualized patient management strategies, by providing education on disease presentation, the importance of genetic testing, symptom management, clinical guidelines, and new advances in the treatment landscape.
Latest content
Learning objectives
Following completion of this independent educational program, you will be able to:
- Recognize the different phenotypes and clinical presentations of late-onset genetic cholestasis
- Integrate consensus recommendations and diagnostic tools to accurately diagnose different types of late-onset genetic cholestasis
- Debate best practice for the current and potential future management of different forms of late-onset genetic cholestasis
- Analyze recent diagnostic and therapeutic advances in late-onset genetic cholestasis and Alagille syndrome, and their relevance to clinical practice
Meet the faculty
Target audience
This program is primarily aimed at a global audience of adult hepatologists and gastroenterologists, but is relevant to all members of the multidisciplinary team that manages late-onset genetic cholestatic patients.
Planning committee
In addition to the expert faculty Springer Health+ IME planners and staff include Rachel Goddard, Rebecca Cox, Alexandros Marantzidis, Lucy Piper, and Lynda Williams. The planning committee have no financial relationships to disclose.
All relevant financial relationships of the faculty have been mitigated.
